The blood spot Cardio Metabolic Profile allows early detection of major indicators associated with metabolic/insulin resistance syndrome. Used as a screening profile this can help clinicians make the most appropriate treatment recommendations to reduce the overall risk of DM2 and CVD. Regular testing can also be used for risk assessment and monitoring patients with DM2. Screening, along with clinical assessment, can be of reliable predictive value for determining overall cardio metabolic risk. The specific markers included in this test are: Insulin, hsCRP, HbA1c, TG, CH, HDL, LDL and VLDL.